Stuart Milstein appointed Chief Platform Officer, bringing decades of experience in oligonucleotide drug development to underpin Aerska’s platform R&DLisa Taylor Ash joins Board of Directors, ...

A newly discovered RNA-based mechanism helps CRISPR systems maintain efficiency by preventing interference, offering insights ...

Nanomedicine prompts RNA to make protein-based drugs to treat diseases. Now we can fine-tune protein production by dialling ...

A Martin-Gatton College of Agriculture, Food and Environment researcher is leading a new project that could help farmers ...

Over the past decade, improved understanding of the physiological and molecular pathology of the cardiovascular system has ...

Arrowhead Pharmaceuticals, Inc. today announced that it will host a webcast and conference call on May 7, 2026, at 4:30 p.m. ET to discuss its financial results for the fiscal 2026 second quarter ...

Detailed price information for Arbutus Biopharma Corp (ABUS-Q) from The Globe and Mail including charting and trades.

TheFly reported on April 7 that Jefferies lowered its price target on ABUS from $7.00 to $5.50 while maintaining a Buy rating ...

An overview of the biologicals regulatory environment, including which regions are most progressive, registration gaps, and ...

Biotechnology in agriculture is making a big splash, offering ways to grow more food, make it healthier, and do it all ...

UAB is an Equal Employment/Equal Educational Opportunity Institution dedicated to providing equal opportunities and equal ...